Livros e artigos selecionados

  • História dos Benzodiazepínicos. Benzodiazepínicos: Quatro décadas de experiência. São Paulo: Editora da Universidade de São Paulo, 1999, v. 1, p. 15-28. 

  • Psychiatrie et santé mentale. La Lecture du Monde. 1ed.Paris: Press Universitaires de France, 1998, v. 1, p. 221-224. 

  • Présent du passé, présent du présent, présent du futur en psychiatrie. In: Pierre Pichot;Werner Rein. (Org.). L'approche clinique en psychiatrie. Paris: Synthélabo, 1993, v. 2, p. 117-137. 

  • Comprehensive Social Psychiatry: Interdisciplinary Extensions. In: Jule H. Masserman;Christine McGuire Masserman. (Org.). Social Psychiatry & World Accords. New York: Gardner Press, Inc., 1992, v. 1, p. 3-4. 

  • New methods of teaching and training the general practitioner. In: M. Gastpar;P. Kielholz. (Org.). Problems of psychiatry in general practice. Bern: Hogrefe & Huber Publishers, 1991, v. 1, p. 161-168. 

  • Giovanni de Girolamo . Neurastenia: History of a Concept. In: N. Sartorius; D. Goldberg; G. de Girolamo; J.A. Costa e Silva; Y. Lecrubier; H.U. Wittchen. (Org.). Psychological Disorders in General Medical Settings. Bern: , 1990, v. 1, p. 69-81. 

  • Comparative double blind study of amisulpride versus haloperidol in the treatment of acute psychotic states. In: P. Borenstein; P. Boyer,;A. Braconnier; P. Carnoy; G. Clerc; J.A. costa e Silva;A. Dufour; F. Gekiere; J.Gruenberger; H. Hippius; C. jacquot; G. Jourdain; Y. Lecrubier; J. margarit; M.C. Maubrey; P. pichot; A. J. Puech; B. Roger; E. Ruether; B. Saletu; B. (Org.). Amilsulpride. Paris: Expansion Scientifique Française, 1989, v. 1, p. 93-104. 

  • L'influence de Pinel au Brésil. Philippe Pinel. Castre: Éditions Médicales Pierre Fabre, 1989, v. 1, p. 121-123.

  • Biomarkers of psychiatric diseases: current status and future prospects. METABOLISM CLINICAL AND EXPERIMENTAL, v. 64, p. S11-S15, 2014. 

  • Personalized medicine in psychiatry:new technologies and approaches. METABOLISM CLINICAL AND EXPERIMENTAL, v. 62, p. S40-S44, 2013. 

  • Aripiprazole for patients with schizophrenia disorder: na open-label, randomized, study versus haloperidol. CNS Spectrums, v. 14, p. 93-102, 2009. 

  • Autism, a brain developmental disorder: some new pathopysiologic and genetics findings. Metabolism, Clinical and Experimental (Print), v. 57, p. S40-S43, 2008. 

  • Sleep Disorders in Psychiatry. Metabolism, Clinical and Experimental (Print), v. 55, p. S40-S44, 2006. 

  • A pathophysiological paradigm for the therapy of psychiatric disease. Nature Reviews. Drug Discovery (Print), v. 4, p. 467-476, 2005. 

  • Overview of the field. Metabolism, Clinical and Experimental (Print), v. 54, p. 5-9, 2005. 

  • Vieillissement cérébral, aspects biologiques et psychosociaux. Bulletin de L'Académie Nationale de Médecine, v. 189, p. 1371-1381, 2005. 

  • Medicines and the drug control treaties: Is buprenorphine for opioid addiction at risk of being lost?. Human Psychopharmacology, v. 19, p. 215-224, 2004. 

  • Citações:1|2

© 2019 Academia Brasileira de Filosofia